TDI01 not checked
Beijing Tide Pharmaceutical Co., Ltd
FollowEvery change as it happens, and a Monday email
Trials
2 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Idiopathic Pulmonary Fibrosis (IPF), GVHD, Chronic
- Main trialPhase 3
- “This study is a multicentre, randomised, double-blind, placebo-controlled, adaptive design clinical trial to evaluate the efficacy and safety of TDI01 suspension in the treatment of idiopathic pulmonary fibrosis (IPF). The study will be conducted in China and divided into two stages, both of which are multicentre, randomised, double-blind, placebo-controlled studies. Stage 1 aims to evaluate the efficacy and safety of TDI01 suspension compared to the placebo group in the treatment of IPF patients, and Stage 2 aims to further confirm the efficacy and safety of TDI01 suspension compared to the…”In the company’s words, NCT07464912 on ClinicalTrials.gov
Other drugs for Idiopathic Pulmonary Fibrosis (IPF)
- SC1011JOYO Pharma · Phase 2/3
- NerandomilastBoehringer Ingelheim · Phase 3
- NAL ERTrevi Therapeutics · Phase 3
- AK3280Shanghai Ark Biopharmaceutical Co., Ltd. · Phase 3
- INS018_055InSilico Medicine Hong Kong Limited · Phase 3
- AdmilparantBristol Myers Squibb · Phase 3
Coming up1
- 30 Jul 2029Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 30 Jul 2029 | A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) | |
| Phase 1/2Active, not recruiting | Feb 2026 | TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD)) | |
| Phase 2Unknown | 1 Aug 2025 | A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026